The role of microglia in multiple sclerosis: implications for treatment with Bruton’s tyrosine kinase inhibitorsPatrick Vermersch, Celia Oreja‐Guevara, Bart Van Wijmeersch et al.|Frontiers in Immunology|2025Cited by 17
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task forceTina Parciak, Liesbet M. Peeters, Lotte Geys et al.|Multiple Sclerosis Journal|2023Cited by 12
The Multiple Sclerosis Data Alliance CatalogueLotte Geys, Liesbet M. Peeters, Tina Parciak et al.|International Journal of MS Care|2021Cited by 11
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year inMaura Pugliatti, Thomas Berger, Hans‐Peter Hartung et al.|Frontiers in Immunology|2022Cited by 11
Generics, Biosimilars and Follow‐On Non‐Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European NeurologistsThomas Berger, Celia Oreja‐Guevara, Markus Zeitlinger et al.|European Journal of Neurology|2025Cited by 4